filmov
tv
Amgen
0:07:18
Amgen CFO talks Q2 earnings, obesity drug, and growth
0:07:56
Dr. Gottlieb on Amgen's new weight loss drug: Expect to be on par with Wegovy & Mounjaro or better
0:10:40
Amgen: How Biotechnology is Transforming Medicine
0:01:05
Cramer’s Mad Dash: Amgen
0:05:05
Amgen has 'a lot to prove' in the weight-loss drug category, says Mizuho's Jared Holz
0:02:31
How Amgen is using Generative Biology and AI
0:01:13
Cell Culture and Expansion - Biotech Manufacturing at Amgen
0:01:15
Welcome to Amgen Ohio
0:47:08
ANÁLISIS TÉCNICO DE ACCIONES: AIRBNB, DISNEY, RIVIAN, DEVON, SHOPIFY, CVS, SONY y AMGEN
0:35:47
Biotechnology and Healthcare: A New Dawn? With Bob Bradway, CEO of Amgen
0:01:45
Amgen’s Research & Development (R&D) Vision
0:02:58
The Next Generation of Biomanufacturing at Amgen
0:01:28
Amgen’s North Carolina Groundbreaking
0:02:07
Amgen has great science, but they don't seem to make it across the finish line, says Jim Cramer
0:03:36
The Amgen Difference - Our People, Our Values
0:00:59
Biologics Manufacturing : Video 1 - Clean Environment
0:01:16
Cramer’s Stop Trading: Amgen
0:01:16
Amgen Shares Soar on Obesity Drug Progress
0:02:24
Amgen Thousand Oaks Virtual Tour
0:01:28
What is the Amgen Foundation?
0:06:49
Amgen's obesity drug plans, outlook for 2024
0:13:11
Welche Aktie hat es ins Depot geschafft ? | Amgen Aktie vs Abbvie Aktie
0:03:57
Amgen (AMGN) - Quick Stock Analysis
0:11:27
Is Amgen Stock a Buy Now!? | AMGN Stock Analysis
Вперёд